These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 18595508)
21. [Tumor markers useful in the diagnostics and monitoring of endometrial and cervical cancer]. Bedkowska GE; Lawicki S; Szmitkowski M Postepy Hig Med Dosw (Online); 2007; 61():122-8. PubMed ID: 17369780 [TBL] [Abstract][Full Text] [Related]
22. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847 [TBL] [Abstract][Full Text] [Related]
23. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report. Puthucode-Easwaran S; Naik R; Athavale R; Handley G; Lopes A; Godfrey K; Hatem M J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586 [TBL] [Abstract][Full Text] [Related]
24. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer]. Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066 [No Abstract] [Full Text] [Related]
25. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx. Eleftheriadou A; Chalastras T; Ferekidou E; Kyriou L; Yiotakis I; Pappas Z; Ferekidis E; Kandiloros D Anticancer Res; 2006; 26(3B):2493-7. PubMed ID: 16821638 [TBL] [Abstract][Full Text] [Related]
26. [Remarkably reduced tumor marker SCC levels by combined chemotherapy of paclitaxel and S-1 in two cases of advanced cervical cancer]. Takagi K; Kougo H; Aoyagi Y; Yonehara T; Minobe S; Azuma M; Yamaguchi T Gan To Kagaku Ryoho; 2008 Feb; 35(2):335-7. PubMed ID: 18281778 [TBL] [Abstract][Full Text] [Related]
27. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis. Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277 [TBL] [Abstract][Full Text] [Related]
29. [Hematopoietic cytokines as tumor markers]. Ławicki S; Mroczko B; Szmitkowski M Postepy Hig Med Dosw; 2001; 55(3):449-65. PubMed ID: 11505643 [TBL] [Abstract][Full Text] [Related]
30. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease. Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Bidzinski M; Kowalska M Tumour Biol; 2016 Jan; 37(1):1271-8. PubMed ID: 26289850 [TBL] [Abstract][Full Text] [Related]
31. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients]. ławicki S; Czygier M; Gacuta-Szumarska E; Knapp P; Szmitkowski M Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841 [TBL] [Abstract][Full Text] [Related]
32. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease. van Dalen A Anticancer Res; 1996; 16(4B):2345-9. PubMed ID: 8694567 [TBL] [Abstract][Full Text] [Related]
33. Concurrent cisplatin-based chemoradiation for cervical carcinoma: tumor response, toxicity, and serum cytokine profiles. Yang YC; Wang KL; Su TH; Liao HF; Wu MH; Chen TC; Huang MC; Chen YJ Cancer Invest; 2006; 24(4):390-5. PubMed ID: 16777691 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853 [TBL] [Abstract][Full Text] [Related]
35. [Lung cancer]. Komagata H; Yoneda S Gan To Kagaku Ryoho; 2004 Oct; 31(10):1609-13. PubMed ID: 15508459 [TBL] [Abstract][Full Text] [Related]
36. Clinical utility of cytokeratins as tumor markers. Barak V; Goike H; Panaretakis KW; Einarsson R Clin Biochem; 2004 Jul; 37(7):529-40. PubMed ID: 15234234 [TBL] [Abstract][Full Text] [Related]
37. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer]. Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876 [TBL] [Abstract][Full Text] [Related]
38. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions. Farzaneh F; Shahghassempour S; Noshine B; Arab M; Yaseri M; Rafizadeh M; Alizadeh K Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of serum tumor markers in head and neck cancer. Martin M; Rayo JI; Talavera JR; Muñoz A; Cañizo A J Nucl Med Allied Sci; 1990; 34(4 Suppl):235-8. PubMed ID: 2092125 [No Abstract] [Full Text] [Related]
40. [Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer]. Joura E; Gitsch G; Kainz C; Fröhlich B; Biegelmayr C; Kölbl H Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():115. PubMed ID: 1286308 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]